These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 30077123)

  • 1. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
    Kaira K; Shimizu K; Kitahara S; Yajima T; Atsumi J; Kosaka T; Ohtaki Y; Higuchi T; Oyama T; Asao T; Mogi A
    Eur J Cancer; 2018 Sep; 101():181-190. PubMed ID: 30077123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
    Kasahara N; Kaira K; Bao P; Higuchi T; Arisaka Y; Erkhem-Ochir B; Sunaga N; Ohtaki Y; Yajima T; Kosaka T; Oyama T; Yokobori T; Asao T; Nishiyama M; Tsushima Y; Kuwano H; Shimizu K; Mogi A
    Lung Cancer; 2018 May; 119():71-77. PubMed ID: 29656756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
    Kasahara N; Kaira K; Yamaguchi K; Masubuchi H; Tsurumaki H; Hara K; Koga Y; Sakurai R; Higuchi T; Handa T; Oyama T; Yokobori T; Shimizu K; Asao T; Hisada T
    Lung Cancer; 2019 Aug; 134():180-186. PubMed ID: 31319979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
    Hu B; Xiao J; Xiu Y; Fu Z; Shi H; Cheng D
    Nucl Med Commun; 2020 Mar; 41(3):252-259. PubMed ID: 32068670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([
    Shimizu K; Kaira K; Higuchi T; Hisada T; Yokobori T; Oyama T; Asao T; Tsushima Y; Shirabe K
    Mol Imaging Biol; 2020 Aug; 22(4):1078-1086. PubMed ID: 31792836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immunity is related to
    Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
    Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
    Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
    Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of
    Togo M; Yokobori T; Shimizu K; Handa T; Kaira K; Sano T; Tsukagoshi M; Higuchi T; Yokoo S; Shirabe K; Oyama T
    Br J Cancer; 2020 May; 122(11):1686-1694. PubMed ID: 32238919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between PD-L1 Expression and Metabolic Activity on
    Takada K; Toyokawa G; Tagawa T; Kohashi K; Akamine T; Takamori S; Hirai F; Shoji F; Okamoto T; Oda Y; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):7073-7082. PubMed ID: 29187498
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hu B; Chen W; Zhang Y; Shi H; Cheng D; Xiu Y
    Ann Nucl Med; 2020 May; 34(5):322-328. PubMed ID: 32130663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer.
    Ishimura M; Norikane T; Mitamura K; Yamamoto Y; Arai-Okuda H; Murota M; Ibuki E; Kanaji N; Nishiyama Y
    Nucl Med Commun; 2022 Mar; 43(3):304-309. PubMed ID: 34908022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
    Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
    Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor metabolic volume by
    Yamaguchi O; Kaira K; Hashimoto K; Mouri A; Shiono A; Miura Y; Murayama Y; Kobayashi K; Kagamu H; Kuji I
    Sci Rep; 2020 Sep; 10(1):14990. PubMed ID: 32929123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between
    Zhao L; Liu J; Wang H; Shi J
    Br J Radiol; 2021 Mar; 94(1119):20200397. PubMed ID: 33492995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
    Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between PD-L1 expression and
    Chen R; Chen Y; Huang G; Liu J
    Aging (Albany NY); 2019 Dec; 11(24):12270-12277. PubMed ID: 31848322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma.
    Wang D; Li Y; Chen X; Li P
    Medicine (Baltimore); 2021 Sep; 100(35):e27100. PubMed ID: 34477147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.